Lymphoma vs Leukemia: What's the Difference?

Lymphoma and leukemia are both cancers that arise from white blood cells, which is why the two are frequently grouped together and sometimes confused. But they are distinct diseases with different points of origin, different typical symptoms, and different treatment pathways. Understanding the difference helps make sense of a diagnosis and the tests used to reach it.

Leukemia begins in the bone marrow, the tissue inside bones where blood cells are produced. A genetic change in an early blood-forming cell causes abnormal white cells to multiply uncontrollably, spilling into the bloodstream and crowding out normal blood cell production.

Lymphoma begins in lymphocytes, a type of white blood cell that is a core part of the immune system and travels through the lymphatic system, a network of vessels and lymph nodes spread throughout the body. In lymphoma, abnormal lymphocytes accumulate primarily in lymph nodes and lymphoid tissue, such as the spleen, rather than mainly in the bloodstream, though it can eventually involve the bone marrow and blood as well.

Leukemia symptoms often relate to low blood counts caused by crowded-out marrow: persistent fatigue, frequent infections, easy bruising or bleeding, and pallor. These can develop quickly in acute leukemias or gradually in chronic types.

Lymphoma more typically presents as painless, enlarging lymph nodes, most often felt in the neck, underarm, or groin. It is also commonly associated with a set of symptoms doctors call B symptoms: fever, drenching night sweats, and unintentional weight loss. Fatigue and itching can also occur. Because swollen lymph nodes are a hallmark of lymphoma, it is sometimes noticed by the patient before any blood test is done, whereas leukemia is more often first flagged by an abnormal complete blood count.

Leukemia is broadly divided into acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), chronic lymphocytic leukemia (CLL), and chronic myeloid leukemia (CML). Lymphoma is broadly divided into Hodgkin lymphoma, identified by a specific abnormal cell called a Reed-Sternberg cell, and non-Hodgkin lymphoma, which covers a wide range of subtypes that vary considerably in behavior and treatment approach.

Leukemia is usually first suspected from a complete blood count and peripheral blood smear, then confirmed with a bone marrow biopsy and additional testing such as immunophenotyping or genetic markers. Lymphoma is usually first suspected from a physical exam finding an enlarged lymph node or from imaging, and is confirmed with a lymph node biopsy, where a sample of the node itself is examined under a microscope. Staging for lymphoma often involves imaging such as a CT or PET scan to see how many areas of the body are involved, which is less central to leukemia staging.

Both cancers can be treated with chemotherapy, but the specific drug combinations, schedules, and additional therapies differ by disease and subtype. Leukemia treatment may include targeted oral therapy, particularly for CML, or bone marrow transplant for select higher-risk or relapsed cases. Lymphoma treatment often combines chemotherapy with immunotherapy antibodies and, for some subtypes, radiation therapy directed at the involved lymph node regions. In both cases, treatment is planned individually based on precise subtype, stage, and the patient's overall health, and many patients respond well to treatment, though outcomes vary by subtype and individual factors.